A meeting of the Board of Directors at Caplin Point Laboratories is scheduled for November 05, 2025. The board will consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2025, on a standalone and consolidated basis. The trading window for designated persons remains closed until November 07, 2025.
Board Meeting Details
Caplin Point Laboratories has announced a meeting of its Board of Directors to be held on November 05, 2025. During this meeting, the board will review and approve the company’s unaudited financial performance.
Financial Results Consideration
The primary agenda of the board meeting is to consider and approve the unaudited financial results for the second quarter (Q2: Jul-Sep) and half-year, which concluded on September 30, 2025. These results will be assessed on both standalone and consolidated bases, providing a comprehensive view of the company’s financial standing.
Trading Window Closure
As previously communicated in the letter dated September 29, 2025, the trading window remains closed for designated individuals and their immediate family members. This restriction will be in effect until November 07, 2025.
Source: BSE
